🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  2. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  3. morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  4. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  5. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  6. nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST-segment Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  7. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials

  8. phacoemulsification

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Astigmatism

    approved other active

    1 trial

  9. physiotherapeutic treatment

    Universal Integrated

    Morquio's Disease

    approved other terminated

    1 trial

  10. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  11. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  12. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  13. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  14. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  15. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  16. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  17. prucalopride

    Takeda

    Chronic Constipation

    approved small molecule completed

    1 trial

  18. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  19. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  20. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  21. sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    3 trials

  22. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial

  23. sIPV+DTaP+HepA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  24. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources